The Evolutionary History of Metastatic Pancreatic Neuroendocrine Tumours Reveals a Therapy Driven Route to High-Grade Transformation
Abstract Tumour evolution with acquisition of more aggressive disease characteristics is a hallmark of disseminated cancer. Metastatic pancreatic neuroendocrine tumours (PanNETs) in particular, show frequent progression from a low/intermediate to a high-grade disease. To understand the molecular mechanisms underlying this phenomenon, we performed multi-omics analysis of 32 longitudinal samples from six metastatic PanNET patients. Following MEN1 inactivation, PanNETs exhibit genetic heterogeneity on both spatial and temporal dimensions with parallel and convergent tumuor evolution involving theATRX/DAXXand mTOR pathways. Following alkylating chemotherapy treatment, some PanNETs develop mismatch repair deficiency and acquire a hypermutator phenotype. This DNA hypermutation phenotype was only found in cases that also showed transformation into a high-grade PanNET. Overall, our findings contribute to broaden the understanding of metastatic PanNET, and suggests that therapy driven disease evolution is an important hallmark of this disease..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
bioRxiv.org - (2024) vom: 12. Jan. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Backman, Samuel [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2024.01.08.24300723 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI042126096 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI042126096 | ||
| 003 | DE-627 | ||
| 005 | 20240113124840.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240111s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2024.01.08.24300723 |2 doi | |
| 035 | |a (DE-627)XBI042126096 | ||
| 035 | |a (biorXiv)10.1101/2024.01.08.24300723 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Backman, Samuel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a The Evolutionary History of Metastatic Pancreatic Neuroendocrine Tumours Reveals a Therapy Driven Route to High-Grade Transformation |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Tumour evolution with acquisition of more aggressive disease characteristics is a hallmark of disseminated cancer. Metastatic pancreatic neuroendocrine tumours (PanNETs) in particular, show frequent progression from a low/intermediate to a high-grade disease. To understand the molecular mechanisms underlying this phenomenon, we performed multi-omics analysis of 32 longitudinal samples from six metastatic PanNET patients. Following MEN1 inactivation, PanNETs exhibit genetic heterogeneity on both spatial and temporal dimensions with parallel and convergent tumuor evolution involving theATRX/DAXXand mTOR pathways. Following alkylating chemotherapy treatment, some PanNETs develop mismatch repair deficiency and acquire a hypermutator phenotype. This DNA hypermutation phenotype was only found in cases that also showed transformation into a high-grade PanNET. Overall, our findings contribute to broaden the understanding of metastatic PanNET, and suggests that therapy driven disease evolution is an important hallmark of this disease. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Botling, Johan |4 aut | |
| 700 | 1 | |a Nord, Helena |4 aut | |
| 700 | 1 | |a Ghosal, Suman |4 aut | |
| 700 | 1 | |a Stålberg, Peter |4 aut | |
| 700 | 1 | |a Juhlin, C. Christofer |4 aut | |
| 700 | 1 | |a Almlöf, Jonas |4 aut | |
| 700 | 1 | |a Sundin, Anders |4 aut | |
| 700 | 1 | |a Zhang, Liang |4 aut | |
| 700 | 1 | |a Moens, Lotte |4 aut | |
| 700 | 1 | |a Eriksson, Barbro |4 aut | |
| 700 | 1 | |a Welin, Staffan |4 aut | |
| 700 | 1 | |a Hellman, Per |4 aut | |
| 700 | 1 | |a Skogseid, Britt |4 aut | |
| 700 | 1 | |a Pacak, Karel |0 (orcid)0000-0002-3541-3767 |4 aut | |
| 700 | 1 | |a Mollazadegan, Kazhan |4 aut | |
| 700 | 1 | |a Åkerström, Tobias |4 aut | |
| 700 | 1 | |a Crona, Joakim |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2024) vom: 12. Jan. |
| 773 | 1 | 8 | |g year:2024 |g day:12 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2024.01.08.24300723 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 12 |c 01 | ||